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ABSTRACT
Air pollution is a severe threat to public health globally, affecting everyone in developed and developing
countries alike. Among different air pollutants, particulate matter (PM), particularly combustion-produced
fine PM (PM2.5) has been shown to play a major role in inducing various adverse health effects. Strong
associations have been demonstrated by epidemiological and toxicological studies between increases in
PM2.5 concentrations and premature mortality, cardiopulmonary diseases, asthma and allergic sensitization,
and lung cancer.Themechanisms of PM-induced toxicological effects are related to their size, chemical
composition, lung clearance and retention, cellular oxidative stress responses and pro-inflammatory effects
locally and systemically. Particles in the ultrafine range (<100 nm), although they have the highest number
counts, surface area and organic chemical content, are often overlooked due to insufficient monitoring and
risk assessment. Yet, ample studies have demonstrated that ambient ultrafine particles have higher toxic
potential compared with PM2.5. In addition, the rapid development of nanotechnology, bringing
ever-increasing production of nanomaterials, has raised concerns about the potential human exposure and
health impacts. All these add to the complexity of PM-induced health effects that largely remains to be
determined, and mechanistic understanding on the toxicological effects of ambient ultrafine particles and
nanomaterials will be the focus of studies in the near future.
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INTRODUCTION
Air pollution is a major global problem associated
with human health in both developing and devel-
oped countries [1–8]. The most common sources
of air pollution include particulate matter (PM),
ozone, nitrogen dioxide and sulfur dioxide [1,3,5,6].
PM can be defined by their different size ranges,
including coarse (<10 μm), fine (<2.5 μm) and
ultrafine particles (UFPs, <100 nm) [4–6,9]. Be-
cause numerous studies have shown that fine PM2.5
particle levels can be linked to premature mortal-
ity and adverse health effects, PM2.5 levels are of-
ten used as a major surrogate for air pollution [1,3–
6,9,10]. According to the World Health Organiza-
tion (WHO) Ambient Air Pollution database that
comprises urban air-quality data for about 1600
cities from 91 countries for the years 2008–13, al-
most 90% of the urban population endured a PM2.5
concentration exceeding the annual mean values of
10 μg/m3 in the WHO air-quality guidelines [6].
In addition, WHO reported that, in 2012, around
7 million people died—one in eight of the total
global deaths—as a result of air pollution exposure
[5]. The new data revealed a stronger link between
both indoor and outdoor air pollution exposure and
the development of respiratory diseases, including
acute respiratory infections, chronic obstructive pul-
monary disease (COPD) and lung cancer, as well as
cardiovascular diseases such as strokes and ischemic
heart disease [5,6,11]. This finding further con-
firmed that air pollution is now the world’s largest
single environmental health risk factor and reducing
air pollution could save millions of lives.
Globally, we are witnessing two opposing trends
in terms of changes in the air pollution levels in dif-
ferent countries. Using new high-resolution global
C©TheAuthor(s) 2016. Published by Oxford University Press on behalf of China Science Publishing &Media Ltd. All rights reserved. For permissions, please e-mail:
journals.permissions@oup.com
REVIEW Xia et al. 417
satellite maps of air quality indicators, NASA sci-
entists tracked air pollution trends from 2005 to
2014 in various regions and 195 cities globally [12].
According to the research findings, the USA, Eu-
rope and Japan have improved air quality owing to
strict emission-control regulations. As a result, in
the USA, reductions in PM2.5 were associated with
lower premature mortality and improvement in life
expectancy. Long-term improvements in air quality
were associated with statistically and clinically sig-
nificant positive effects on lung-function growth in
children [13]. On the contrary, China, India and the
Middle East countries, with their rapid population
growth, fast-growing economies and vastly expand-
ing industrialization, have shown alarming increases
in air pollution, along with increased mortality and
disease burden in those countries [14]. On a pos-
itive note, in recent years, China’s overall air qual-
ity has seen early signs of improvement due to a de-
crease in coal consumption, increase in renewable
energy sources and stricter emission control. It is
worth noting that, although air pollution mostly is
considered a local or regional problem, studies have
shown that air pollution could be transported over
long distances, even across continents, in the tropo-
sphere [15]. Thus, mitigation of local air pollution
could have far-reaching health benefits and a collec-
tive effort between every country involved would be
important.
Despite the progress in our understanding of
air pollution-induced diseases, much research re-
mains to be done [1,8,9,14,16]. For instance, among
the PM fractions, UFPs possess the highest particle
number and surface area, carrying higher chemical
contents than PM2.5 [4,17–20]. Studies have shown
thatUFPshave detrimental effects onboth the respi-
ratory and cardiovascular systems, and exacerbation
of asthma [2–4,17,21,22]. However, our under-
standingofUFPs is still incomplete because of a defi-
ciency in extensiveUFP-monitoring networks, rapid
physicochemical characterization techniques, and
limited epidemiological and toxicological studies. In
addition, the rapid advances in nanotechnology lead
to production of high volumes of nanomaterials and
increasing use in commercial products [18,23,24].
The use of nanomaterials increases the potential for
human exposure to nanomaterials that could gener-
ate adverse health effects. For instance, ceria (cerium
dioxide) are used in diesel as a catalyst to pro-
mote the combustion process, which are released
in the diesel exhaust, potentially leading to lung ex-
posure. The addition of ceria to diesel fuel resulted
in ceria-concentration-dependent emission reduc-
tions of CO2, CO, total particulate mass, formalde-
hyde, acetaldehyde, acrolein and several polycyclic
aromatic hydrocarbons; however, it also led to
decreases in the size of emitted particles and a sub-
stantial increase in the number ofUFPs (+32%), to-
gether with increases in certain other air pollutants,
specifically NOx (+9.3%) and the particle-phase
benzo[a]pyrene toxic equivalence quotient (+35%)
[25].This shows the complexity of the potential im-
pacts introduced by nanomaterials. Given the health
concerns related toUFPs and increasingly produced
and used nanoparticles, further research is needed to
evaluate the health risks associated with these tiny
particles.
EPIDEMIOLOGICAL STUDY LINKING PM
TO PREMATURE MORTALITY
Evidence that links ambient PM to a decrease in
life expectancy and increase in premature mortality
came from epidemiological studies that have been
extensively reviewed before [1,7,8,24,26–28]. In
a recent study, Chen et al. presented findings that
implicated long-term exposure to air pollution
particles contributed to enormous loss of life
expectancy in China [26]. These results were based
on an experimental design making use of a Chinese
policy that provided free coal for heating in cities
located north of Huai River, but not in the south,
which produced an arbitrary discontinuity for PM
air pollution, where the major difference was coal
combustion. As a result, mean life expectancy is
about 5.5 years (95% conficence interval (CI): 0.8,
10.2) lower in northern compared with southern
China due to an increased incidence of cardiores-
piratory mortality [26]. This finding correlated well
with a study by Pope et al. that used a temporal
difference in PM levels observed since the 1990s,
when air quality across cities in the USA improved
substantially. They found that there was an associ-
ation between reductions in PM2.5 and an increase
in life expectancy; a reduction of 10 μg/m3 was
associated with an increase of 0.61 years in life
expectancy [8]. There was also a strong evidence
base for morbidity and mortality associated with
both short-term (days to weeks) and long-term
(years to decades) PM exposures. Early evidence
linking ambient PM to mortality came from well-
documented short-term extreme air pollution
episodes (that lasted for days) in the 1930s to 1950s
[28]. More recently, numerous daily time-series
and case-crossover studies have observed a small
but statistically robust relationship between daily
mortality and short-term (days to weeks) elevation
in PM [28]. In addition, short-term air pollution
exposure could also increase the mortality rate of
patients with respiratory diseases. For example, Cui
et al. evaluated air pollution using the air pollution
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Figure 1. The contribution of outdoor air pollution sources to premature mortality on a global scale. The data were derived
from a global atmospheric chemistry model that links premature mortality to outdoor air pollution, mostly by PM2.5. Study
found that, in 2010, outdoor air pollution, mostly by PM2.5, leads to 3.3 million premature deaths per year worldwide, pre-
dominantly in Asia. Unit of mortality was expressed as deaths per area of 100 km× 100 km (color-coded). In the white areas,
annual mean PM2.5 and O3 are below the concentration–response thresholds where no excess mortality is expected. The
figure was originally published by [14] and has been approved for reuse by Nature Publishing Group.
index (API) derived from the concentrations of
particulate matter, sulfur dioxide, nitrogen dioxide,
carbon monoxide and ground-level ozone and their
relationship with the case fatality of severe acute
respiratory syndrome (SARS) in China [29]. Case
fatalities of patients from regions with high APIs
(API > 100) and moderate APIs (75–100) were
compared with that of patients from regions with
low APIs (API < 75). The study showed that the
case-fatality rate increasedwith the increment ofAPI
(case fatality = –0.063 + 0.001 × API). The cor-
relation coefficient between API and SARS fatality
was 0.8568 (P= 0.0636) [29]. Short-term exposure
demonstrated that SARS patients from regions with
moderate APIs had an 84% increased risk of dying
from SARS compared with those from regions
with low APIs (relative risk (RR) = 1.84, 95% CI:
1.41–2.40). Similarly, SARS patients from regions
with high APIs were twice as likely to die from SARS
compared with those from regions with low APIs
(RR = 2.18, 95% CI: 1.31–3.65). For long-term
studies, two large-scale prospective cohort studies in
the USA showed that there were statistically robust
associations between mortality risk and PM2.5
exposure even after smoking and other risk factors
were controlled for [8,27]. Long-term air pollution
exposure could also increase the mortality rate of
patients with respiratory diseases such as SARS
[29]. Although ecologic fallacy and uncontrolled
confounding effects might have biased the results,
the possibility of an effect of air pollution on the
prognosis of SARS patients was indicated [29].
In a recent study, Lelieveld et al. used a global
atmospheric chemistry model to investigate the
link between premature mortality and ambient
PM2.5 concentrations [14]. The authors found that
more than 3.2 million deaths per year could be
attributed to outdoor PM2.5 exposure. The majority
of the mortality happened in Asia, which strongly
influenced the global mortality rate. The highest
number of deaths was in the Western Pacific, where
China was the main contributor (1.36 million
per year). Southeast Asia had the second highest
premature mortality, where India was the main
contributor (0.65 million per year) (Fig. 1) [14].
This was in addition to the estimated 3.54 million
deaths per year caused by indoor air pollution
resulting from biomass or coal combustion for
cooking and heating [14]. The cause of premature
mortality includes lung diseases, such as Chronic
obstructive pulmonary disease (COPD), lung
infection and cancer (described in detail below), as
well as cardiovascular diseases and cerebrovascular
diseases, etc. [14]. In addition, many birth cohort
studies have linked PM2.5 exposure to asthma and
allergic diseases [3,30]. Altogether, a large amount
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Figure 2. General toxicological pathways linking PM lung exposure to cardiovascular and cerebrovascular diseases that
cause morbidity and mortality. The first line of defense against PM is the lung, where PM can induce or exacerbate lung
diseases including COPD, asthma, lung infection disease and lung cancer. Furthermore, UFPs could translocate out of the
lung into the blood stream and can cause systemic inflammation and oxidative stress that negatively impact blood and blood
vessel, heart function and brain.
of literature provided evidence that breathing
combustion-related PM2.5, even at exposure levels
common to urban populations worldwide, con-
tributed to cardiorespiratory disease mortality and
diminished the lifespan [1,7,8,14,28].Therewas also
encouraging evidence showing that improvement
in air quality benefited human health and increased
the lifespan [8,27]. For example, long-term im-
provements in air quality were associated with a
significant improvement in lung function in children
[13]. However, there are no conclusive data yet
available for the human health impacts of ambient
ultrafine particles and engineered nanoparticles,
which warrant further studies.
AIR POLLUTION PARTICLE-INDUCED
PULMONARY DISEASES
The lung is the first target organ for air pollution
and PM exposure is associated with reduced lung
function, increased lung inflammation, asthma,
respiratory infections, lung cancer and exacerbation
of COPD, which lead to systemic inflammation and
oxidative stress affecting blood, vasculature, heart
and brain, ultimately contribute to the premature
mortality (Fig. 2) [3,8,14,16]. It is notable that
the acute adverse health effects of PM are most
often found in susceptible populations, including
children, elderly people and those with chronic
diseases [3,7], while not obvious for short-term
exposure in normal healthy people except at very
high concentrations [17]. However, air pollution
exposure could induce adverse health effects to nor-
mal healthy people [17]. A panel study conducted
among Chinese healthy adults during the Beijing
Olympics found that peak expiratory flow levels
increased in 78% of the participants when compared
with the during- and pre-Olympics time points,
while peak expiratory flow levels decreased in 80%
of participants for the post- and during-Olympic
periods comparison [31]. Children are more
susceptible to air pollution because they have
smaller airways, higher breathing rates per body
mass, immature detoxification and metabolic
systems, and they are more frequently exposed
to outdoor air [3,10]. The elderly population and
people with chronic diseases are susceptible likely
because of less efficient particle clearance in the lung
or impairment of immune functions. The adverse
effects induced by air pollution are not limited to
420 Natl Sci Rev, 2016, Vol. 3, No. 4 REVIEW
the lung, PM could induce systemic inflammation
and oxidative stress, and nano-sized particles could
even translocate out of the lung to other tissues
and organs, which induces pathological changes in
blood, vasculature, heart and brain (Fig. 4) [17,23].
The main pulmonary diseases that are associated
with PMs are the following.
COPD
COPD is not only associated with smoking, but also
has high incidence among non-smokers [3,32,33].
The risk factors for COPD among non-smokers in-
clude indoor air pollution frombiomass combustion
and second-hand tobacco smoke, as well as occupa-
tional exposures and outdoor air pollution [32–34].
Epidemiological studies from both developing and
developed countries have shown the association be-
tweenoutdoorPMexposure andCOPD. In addition
to PM, ozone and NO2 could also exacerbate
COPD. An increase in ambient PM2.5 could in-
duce acute exacerbations andmortality fromCOPD,
while improvement in air quality decreases the inci-
dence of COPD [32–34].
Asthma
Abundant evidence has shown that air pollution
could induce and exacerbate asthma [35]. In a re-
centmeta-analysis of several birth cohort studies, the
authors suggested that early childhood exposure (1–
12 years old) to traffic-related air pollution (TRAP)
containing UFPs and PM2.5 were associated with
increased incidence of asthma and risk of sensiti-
zation to common allergens [30]. Furthermore, a
10-year longitudinal study of 23,704 adults from
eight European countries showed an association be-
tween TRAP exposure and increased incidence of
asthma[36].Theauthors found that adult asthma in-
cidencewaspositively associatedwith exposuremet-
rics, including PM10, PM2.5, nitrogen oxides, traffic
load and intensity. Further research with improved
personal-level exposure assessment (vs. residential
exposure assessment only) and phenotypic charac-
terization was recommended by the authors [36].
Lung cancer
In October 2013, the International Agency for Re-
search on Cancer (IARC) of WHO announced that
outdoor air pollution and PM were classified as a
Group I carcinogen,whichwas determinedbased on
themost recent data fromhuman, animal andmech-
anistic studies [11]. In one of the first studies of lung
cancer among female non-smokers in China with
measured indoor exposure to PM1, PM2.5, PM7,
PM10 and total suspended particulate (TSP), Mu
et al. reported that the PM1 levels in cases weremore
than three times higher than those in the controls.
Every 10 μg/m3 increase in PM1 is associated with
a 45% increased risk of lung cancer [37]. Multiple
studies in recent years have shown a correlation be-
tween air pollutants including PM2.5 and NO2 and
lung cancer risk [3,38–40]. In 2010 alone, 223,000
deaths from lung cancer worldwide were associated
with air pollution [11].
Lung infections
Recent data showed that air pollutionwas associated
with respiratory infections, due to the impaired im-
mune functions of the lung and the susceptible pop-
ulation including children, elderly people and those
with chronic diseases [41,42]. Two recent epidemi-
ological studies demonstrated associations between
air pollution (TRAP and ozone) and acute respira-
tory infections as well as increased emergency de-
partment visits in young children [41,42].
PHYSICOCHEMICAL PROPERTIES OF AIR
POLLUTION PARTICLES
The most common sources of air pollution include
PM, ozone, nitrogen dioxide and sulfur dioxide
[3,7,14]. Among these components, PM has been
shown to play a major role in human morbidity
and mortality [3,7,14]; thus, we will focus our dis-
cussion on PM. PM comes from natural and an-
thropogenic activities and processes [3,4,7,14,24].
Anthropogenic sources of outdoor PM are high-
temperature processes (e.g., welding, smelting),
combustion (e.g., power generation, land traffic, res-
idential and commercial heating and cooking), in-
dustrial and other processes, including agriculture,
dust and biomass burning. Indoor PM sources are
mostly biomass and coal combustion for cooking
and heating purposes [3,4,7,14,24]. Although the
physiochemical properties (chemical composition,
metal content, etc.) of PM are different worldwide,
they are all associated with adverse human health ef-
fects although at different potency levels [14]. PM10
is referred to the mass of particles collected with
50% efficiency for particles with an aerodynamic di-
ameter equal to or less than 10 μm; it should be
noted that all particles down to the ultrafine size
range were collected [17]. At this size range, accord-
ing to the International StandardsOrganization tho-
racic convention, the mass fraction of inhaled par-
ticles could penetrate beyond the larynx to the air-
ways [23]. PM2.5 refers to the respirable fraction
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Figure 3. TEM images of ambient ultrafine particles and en-
gineered nanoparticle as well as particle characteristics that
promote or contribute to ROS generation. (a) Photoactivation
effects of NPs, such as the formation of electron–hole pairs
during ultraviolet exposure of TiO2; this effect has been as-
sociated with the generation of oxidative stress and inflam-
mation by TiO2; (b) discontinuous crystal planes and material
defects of NPs that lead to oxygen radical generation due to
the active electronic state of the material surface; (c) redox
cycling contributes to ROS production. This can occur due
to the presence of transition metals or redox-cycling organic
chemicals on the PM, UFP and NP surfaces. PMs and UFPs,
for example, contain organic compounds such as quinones,
which can generate ROS through redox cycling. Moreover,
transition metals can generate hydroxyl radicals through the
Fenton reaction. The Fenton reaction is one of the mech-
anisms by which metal impurities on the CNT surface can
induce ROS production. Finally, (d) particle dissolution (e.g.
ZnO, CdSe, Cu) can produce free ions that are capable of in-
ducing ROS generation and oxidative stress in cells. Metal
fume fever is a real-world example of this toxicity, commonly
for welders.
that also contains the ultrafine component, which
penetrates to the unciliated regions of the lung and
is now being considered worldwide as the standard
[23]. Ultrafine particles are found to a large extent
in urban air as both singlet and aggregated particles
(Fig. 3), and indeed are the predominant particle
type by number in urban PM10 and PM2.5, although
they contribute insignificantly to mass [4,18,23,24].
PM from combustion processes characteristically
has an elemental or organic carbon core carrying
trace metals, sulfate, ammonium, and volatile and
semi-volatile components [43,44].The composition
of combustion-generated PM usually depends on
fuel type, burn conditions and atmospheric con-
ditions. Compared with PM10 and PM2.5, traffic-
derived UFPs are challenging to characterize ge-
ographically or spatiotemporally, as their concen-
trations decrease sharply downwind from sources,
and UFPs shift in size from nucleation mode to
accumulation mode with time and distance from
their emission point due to agglomeration and con-
densation [45–47]. For combustion sources, the
fuel, combustion conditions and pollution controls
will alter the particle numbers and size distribu-
tion of the PM emitted [43,44]. However, studies
have shown that UFPs carried more organic chem-
icals due to their significantly larger surface area;
many of these compounds were redox-active and
had the ability to generate reactive oxygen species
(ROS) [43,44]. Studies have shown that UFPs were
more toxic than their larger counterparts; however,
more research is needed to clarify the role of UFPs
[17,21,22]. Nanoparticles (NPs) are intentionally
created with specific size, shape, surface character-
istics and functionality that are required for their
applications [18,23]. There are similarities between
NPs andUFPs; however, there are also major differ-
ences (Table 1). NPs and PM including UFPs could
both generate ROS or release toxic ions through dis-
solution, through similar or different mechanisms
(Fig. 3) [18,24,48]. Although currently there is no
definitive evidence to link NP exposure to any hu-
man disease, much experimental data indicate that
some NPs with certain physicochemical properties
may be potentially hazardous [19,49–59]. Obvi-
ously, more research is needed on this front.
DIFFERENT DEPOSITION PROFILES AND
HAZARD POTENTIALS OF PARTICLES
WITH DIFFERENT SIZES
The potency of PM in causing an adverse health
impact is dependent, in part, on its deposition in
the airways and chemical composition [17,23]. The
main depositionmechanisms in the respiratory tract
for inhaled PM include impaction, sedimentation,
interception and diffusion [23]. PM in different size
ranges has drastic differences in distribution and de-
position in the lung [23]. This is clearly demon-
strated in Fig. 4, which shows the differential de-
position of inhaled particles with different sizes
in the nasopharyngeal, tracheobronchial and alve-
olar regions of the human respiratory tract [23].
For UFPs and NPs that are in the size range of
1–100 nm, the particles could penetrate deeper into
the alveolar region anddeposit there at high percent-
ages. For larger particles including PM10 and PM2.5,
they generally deposit in the nasopharyngeal and
laryngeal region and poorly deposit in the alveolar
region (Fig. 4) [23].
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Table 1. Comparison of ambient PM2.5, UFPs and NPs.
Particle type PM2.5 UFPs NPs
Size <2.5μm, containing UFP
component
<100 nm, exist alone or as a
component of PM2.5
<100 nm for at least one dimension
Sources Incidental (combustion) Incidental (combustion) Engineered (controlled synthesis)
Morphology Irregular (chain-like structure) Irregular (chain-like structure) Regular (sphere, tube, cube, rod,
wire, plate, etc.)
Homogeneity No No Yes
Organic chemical
content
Low (compared with UFPs) High (compared with PM2.5) None to very low levels
Metal impurity High High Varies
ROS generation Yes Yes Varies
Exposure route Inhalation Inhalation Inhalation, dermal, ingestion, injection
Adverse health effects Yes Yes Largely unknown
Figure 4. Predicted fractional deposition of inhaled particles in the nasopharyngeal and laryngeal, tracheobronchial and
alveolar regions of the human respiratory tract during nose breathing. Please note the clear changes in the deposition rate
at these lung regions between nano-sized particles and their larger counterparts. The figure was originally published by [23].
The different deposition profiles among parti-
cles with diverse sizes could at least partially ex-
plain their different health effects [17,23]. For ex-
ample, the deposition site determines the clearance
rate of particles [17,23]. For large particles includ-
ing PM10 and PM2.5, the majority deposited in the
upper airways could be removed with the mucus via
the mucociliary escalator (Fig. 5). The small frac-
tion of particles that could pass through upper air-
ways into the alveolar region (Fig. 4), such as PM2.5
fine particles, could be easily endocytosed and re-
moved by alveolar macrophages (Fig. 5). However,
for UFPs and NPs, the majority of these particles
could pass through the airways into the alveolar re-
gion. Although they also deposit in the larger air-
ways, this only accounts for a small percentage of
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Figure 5. Scheme for physicological and toxicological events occurring after PM2.5
and UFP/NP exposure. PM2.5 mostly sticks to the airway, where they are cleared by
mucociliary escalator. The remaining PM2.5 particles that get inside the alveoli will be
phagocytosed by resident macrophages. However, for UFPs and NPs, themajority of the
particles will get inside the alveoli, where the cellular uptake of nano-sized particles
by macrophages is impaired, leading to delayed clearance of particles and generating
oxidative stress and pro-inflammatory effects by macrophages and epithelial cells be-
cause of prolonged exposure to particles. The prolonged interaction between particles
and the epithelium also lead to extrapulmonary translocation to the lung interstitium
and even into the circulation. Adapted from [17].
the total number of particles in the lung. Further-
more, the particles are so tiny and in such vast num-
bers that macrophages could not take them up effec-
tively (Fig. 5) [17,23].The interactions amongparti-
cles, epithelial cells andmacrophages could generate
oxidative stress and pro-inflammatory effects in the
lung, and there are reports showing that nano-sized
UFPs could be more toxic than their larger coun-
terparts (which will be discussed in later sections)
[2,17,21,23]. In addition, extrapulmonary transloca-
tion across the epitheliumcouldoccurbecauseof the
reduced removal rate and longer retention of UFPs
andNPs that allows transcytosis of these nano-sized
particles [17,23].This could lead to secondary depo-
sition of these particles in other tissues and organs,
which may contribute to further adverse health ef-
fects (Fig. 5) [17,23].
OXIDATIVE STRESS PLAYS A MAJOR
ROLE IN PM-INDUCED PULMONARY
DISEASES
Emerging evidence has shown that, among different
particles, UFPs are potentially the most danger-
ous owing to their small size, deep penetration,
large surface area/volume ratio, high content of
redox-cycling organic chemicals, alveolar deposition
and high rates of retention in the lung [4,21,22].
Compared with PM10 and PM2.5, traffic-derived
UFPs are capable of carrying more organic chem-
icals on their significantly larger surface; many
compounds (polycyclic aromatic hydrocarbons
(PAHs) and quinones) are redox-active and have
the ability to generate ROS [4,20–22,24,44,60].
While PM10 and PM2.5 can be easily removed by
phagocytosis, the extremely small size of UFPs
enables them to evade such a process and UFPs
could have more interactions with other cell types
in the lung (Fig. 5) [17,23]. These specific fea-
tures of UFPs can significantly contribute to the
adverse effects through ROS over-production by
the redox-active organic chemicals and metals
on particle surface, resulting in cellular oxidative
stress [18,19,21,44,48]. Oxidative stress has been
identified as a major mechanism for PM10-, PM2.5-
and UFP-associated health effects, including
exacerbation of asthma and COPD, and promo-
tion of atherosclerosis [18,19,21,22,44,48]. Some
NPs, including carbon nanotubes, silver nanopar-
ticles, ZnO, CuO, etc., have also been shown
to be able to generate ROS and oxidative stress
[19,55,56,58,59,61]. At the cellular level, particle-
induced oxidative stress can activate a cascade of
signaling pathways that mediate the production of
pro-inflammatory cytokines/chemokines and in-
duce apoptosis (Figs 6 and 7) [18,48,53], resulting
in inflammation and tissue injury in the respiratory
and cardiovascular systems [17,33,38].
MOLECULAR MECHANISMS OF
PM-INDUCED OXIDATIVE STRESS AND
TOXICITY
PM-induced ROS production in biological systems
and targeted cells originates froma variety of sources
(Fig. 6) [18–21,24,44,60]. These include: (i) car-
bon core of PM and UFPs could induce ROS gen-
eration and oxidative stress; (ii) catalytic conver-
sion of PAHs to quinones by cytochrome P450 in
the endoplasmic reticulum; (iii) quinone redox cy-
cling by NADPH-dependent P450 reductase in mi-
crosomes; (iv) mitochondrial perturbation leading
to electron leakage in the inner membrane; and (v)
NADPH oxidase activity in the macrophage sur-
face membrane and associated phagosomes. Both
the carbon cores as well the chemicals coated on
their surface play a role in these biological events
[2,17,44].This also includes the involvementof tran-
sitionmetals in generatingROSby aFenton reaction
[2,17,44].
The PM backbone is formed by chain-like
carbon-based nanoparticles. To see whether
the particles themselves could induce ROS and
adverse effects, ultrafine carbon black was selected
as the model particle. Studies found that ultrafine
424 Natl Sci Rev, 2016, Vol. 3, No. 4 REVIEW
Figure 6. Sources of PM- and UFP-induced ROS production and their cellular effects.
Quinones, under the catalytic influence of NADPH-cytochrome P450 reductase, can re-
dox cycle to produce ROS in the endoplasmic reticulum. Phagocytosis can induce the
assembly and activation of NADPH oxidase to produce superoxide. UFPs can interfere
in electron transduction in the mitochondrial inner membrane as well as perturb the PT
pore to generate ROS. ROS induce lipid peroxidation in the cell membrane, cross-linking
of protein thiol (SH) groups and DNA damage. ROS can also deplete glutathione (GSH),
resulting in oxidative stress in the cell. Depending on the levels of oxidative stress, the
response could range from induction of Nrf2 release to the nucleus, activation ofMAPK
and NF-kB signaling cascades, or cytotoxicity. According to the hierarchical oxidative
stress hypothesis, Nrf2 interaction with the antioxidant response element (ARE) leads
to heme oxygenase 1 and other phase II enzyme expression at lower levels of oxida-
tive stress (Tier 1), while, at a intermediary level of oxidative stress, activation of the
MAPK and NF-kB signaling cascades can induce pro-inflammatory responses (e.g. cy-
tokine and chemokine production) (Tier 2). At the highest oxidative stress level (Tier 3),
ROS can induce the opening of the mitochondrial PT pore, followed by cytochrome c
release, caspase-3 activation and induction of programmed cell death.
carbon black could generate ROS in cell-free
systems and cause oxidative stress to cultured cells
[2,17,23]. In addition, ultrafine carbon black caused
systemic pro-inflammatory responses in the lung
including modest neutrophil influx and protein leak
[17,23]. There was evidence of systemic oxidative
stress in the plasma and increased production of
plasma factor VII, which is an independent risk
factor for cardiovascular disease [17,23].
Redox-cycling organic chemicals on PM sur-
faces, such as quinones, are capable of generating
ROS in cellular targets such as bronchial epithelial
cells, macrophages and endothelial cells [24,44,60].
Quinones are byproducts of fossil fuel combustion,
as well as the enzymatic conversion of PAH in the
lung. Redox-cycling quinones undergo one-electron
reductions mediated by NADPH-cytochrome
P450 reductase to form semiquinones. These
semiquinones are metastable and donate electrons
to O2, leading to the formation of O2•−. Due to
their high content of organic chemicals, ambient
UFPs contribute proportionally more redox-cycling
chemicals than larger particles [4,24,44,60].
Catalytically active metals adsorbed on the PM
surface have been shown to contribute to oxidative
stress in vitro and in vivo [4,24,60]. PM contains a
number of transition metals (coarse> fine>UFP)
that contribute toROSproduction. Among the tran-
sition metals, Fe, Al, Cu, Ni, Mn, Zn, Cr, Ba and
Sr are the most abundant [44]. In the presence of
hydrogen peroxide, some of these metals, including
Fe2+, have the ability to generate the hydroxyl radi-
cal (•OH) through catalysis of a Fenton reaction:
Fe2+ + H2O2 → Fe3++•OH + OH−.
The •OH radical is more reactive than O2•−
and hydrogen peroxide by several orders of magni-
tude. Besides ROS generation, transitionmetals also
have the ability to directly perturb the function of
themitochondrial permeability transition (PT)pore
[24,44,60]. Transition metals may also act synergis-
tically with other PM components in impacting mi-
tochondrial function, ROSgeneration, ATPproduc-
tion and cell viability [24,44,60].
PM components could perturb mitochondrial
function, leading to generation of ROS and cell
death [21,60]. Mitochondria have been shown to
be a direct subcellular target for ambient UFPs. For
example, ambient UFPs have been found to lodge
in the mitochondria of target cells and cause mito-
chondrial damage [21]. Although the mechanism
of mitochondrial localization is still elusive, we hy-
pothesize that particle size, hydrophobicity andpres-
ence of organic chemicals may play a role in the
process. In addition to direct effects, studies have
found that organic PM chemicals are capable of gen-
erating ROS by their ability to interfere in these
electron transfer events. This includes the effect of
polar chemicals such as redox-cycling quinones to
disrupt electron transfer in the inner membrane
[44].This disruption in electron flow could favor the
formation of ubisemiquinones, thereby contribut-
ing to mitochondrial O2•− production. In addi-
tion, organic chemicals such as quinones and PAHs
also have the capability to perturb the mitochon-
drial PT pore (Fig. 6) [44,60]. The PT pore is
a redox-, pH-, calcium- and m-dependent pro-
tein complex, which plays a pivotal role in regulat-
ing mitochondrial function and controlling cellular
apoptosis. Opening of the PT pore could lead to
mitochondrial swelling and rupture of the mito-
chondrial outer membrane, by which various pro-
apoptotic proteins such as cytochrome c, SMAC,
apoptosis-inducing factor (AIF), etc., are released
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Figure 7. Potential mechanisms of PM-, UFP- and NP-induced NLRP3 inflammasome
activation and IL-1β production. Activation of NLRP3 inflammasome complex can be
induced by various stimuli including PM and NP particles, and the pro-IL-1β is pro-
cessed by the inflammasomes to produce mature IL-1β , while IL-1β plays a major role
in inducing the pro-inflammatory and pro-fibrogenic effects in the lung. NLRP3 inflam-
masome activation requires two signals in vitro. For signal 1, pathogen-associated
molecular patterns (PAMPs) such as LPS is recognized by Toll-like receptor 4 (TLR4)
residing on the cell membrane, which further leads to NF-κB activation and the pro-
duction of pro-IL-1β andNLRP3 proteins. NLRP3 inflammasome activationmechanisms
include ROS generation, potassium efflux, lysosomal damage and cathepsin B release.
After phagocytosis of PM, UFPs and NPs, NADPH oxidase is activated to generate
ROS. The over-production of ROS may cause the destabilization and permeabilization
of lysosomes and cathepsin B release, which will initiate the inflammasome activation
cascade. Mitochondrion is another important source of ROS in cells. Over-production
of mitochondrial ROS could lead to release of mtDNA and cardiolipin that could in-
duce NLRP3 inflammasome activation. In addition, potassium efflux induced by par-
ticles could also induce mitochondrial and cellular ROS production leading to NLRP3
inflammasome activation. Levels of activated NLRP3 inflammasomes are tightly regu-
lated by autophagy.
into the cytosol where they activate a number
of apoptotic pathways, ultimately leading to pro-
grammed cell death [18,24,44,48,60,62].
PM-, UFP- and NP-induced oxygen radical gen-
eration can result in cellular and tissue injury re-
sponses such as inflammation, apoptosis, necrosis,
fibrosis and carcinogenesis [18,20,48,63]. Cellular
oxidative stress can generate a wide range of re-
sponses that can be experimentally detected, in-
cluding damagedDNA—mainlyDNA single-strand
breaks or generating 8-oxo-2′-deoxyguanosine (8-
oxo-dG) that promote cell turnover and prolifer-
ation [63]. At the lowest level of oxidative stress
(Tier 1), the induction of antioxidant and pro-
tective responses is mediated by the transcription
factor Nrf2, which regulates the activation of the
antioxidant response element in the promoters of
phase II genes [18,64]. As the levels of oxida-
tive stress increases (Tier 2), this protective re-
sponsemay yield to pro-inflammatory responses be-
cause ROS induces redox-sensitive signaling path-
ways such as the mitogen-activated protein kinase
(MAPK) and nuclear factor-kappa B (NF-κB) cas-
cades [18,20,24,53,60]. At the highest level of ox-
idative stress (Tier 3), a perturbation of mito-
chondrial inner membrane electron transfer and
the open/close status of the PT pore can trigger
cellular apoptosis and cytotoxicity. This outcome
is also known as toxic oxidative stress (Fig. 6)
[18,20,24,53,60]. Using this three-tier screening
platform, we have also shown for ambient air-
pollution particles that one can link the hierarchical
oxidative stress paradigm to the in vivo outcomes in
animal disease models [18,20,24,53,60]. Oxidative
stress is also involved in mutagenesis [65]. Future
screening could also include DNA damage and mu-
tagenesis tests to assess their carcinogenic potential.
HAZARD POTENTIAL OF
NANOPARTICLES IS DETERMINED BY
THEIR PHYSICOCHEMICAL PROPERTIES
NPs are intentionally created with specific size,
shape, surface characteristics and function-
ality that are required for their applications
[18,23,24,48,53,66]. Although currently there is
no definitive evidence to link NP exposure to any
human disease, experimental data indicate that
many NPs may be potentially hazardous [19,49–
52,54–56,58,59,61,67,68]. The physicochemical
characteristics of NPs that may have health impli-
cations include particle size, shape, aspect ratio,
composition, surface reactivity, solubility and ability
to generate ROS [18,48,53]. Similar to UFPs,
the nano-scale size can enhance NP translocation
and deposition by interfering with their clearance
[17,23]. NP composition or modification may
affect particle surface reactivity such as the ability
to generate ROS, which is an important mediator
involved in various human diseases. However, UFPs
and NPs are inherently different in many aspects,
such as source, morphology, organic chemical
content, homogeneity, ROS production, possible
exposure route and the potential adverse health
effects (Table 1). Extensive in vitro and in vivo
studies have been performed to elucidate the toxic
effect of engineered nanomaterials (ENMs) and
physicochemical properties of ENMs, including
morphology, size, dissolution, aspect ratio, surface
coating, surface reactivity, bandgap and aggregation,
have been suggested to determine their toxicity
potentials [17,18,23,48,53]. For example, CeO2 has
excellent antioxidant properties that are enabled
by the duality of the cerium ion to easily cycle
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between Ce4+ and Ce3+; it is widely used as a
catalyst or fuel additive in diesel to facilitate the
combustion process and is released into the air as
exhaust. There are reports over the past few years
that utilize the antioxidant property of CeO2 in
treating diseases such as cancer, Alzheimer’s, cardiac
arrest, radiation-induced cell death and aging [69].
However, a recent study found that CeO2 NPs
could lead to a decrease in cell viability and the
treated cells exhibited characteristic hallmarks of
apoptosis [70]. In this case, CeO2 NP toxicity is
caused by mitochondrial damage leading to AIF re-
lease, but not caspase activation or ROS production.
Moreover, CeO2 NP exposure leads to autophagy
and inhibition of autophagy partially reverses cell
death by CeO2 NPs [70]. Obviously, more research
should be done to clarify the effects of CeO2 under
in vitro and in vivo conditions.
TiO2 is the most widely produced nanomaterial
and is found in cosmetics, sunscreen, paint, vitamins,
toothpaste, food colorants, nutritional supplements,
etc. However, study has shown that TiO2 nanoparti-
cles could causeoxidative stress-mediated acute lung
inflammation. Oberdorster et al. have shown that,
on a mass-dose basis, ultrafine TiO2 is more toxic
than fine TiO2 [23]. However, when the doses of
particles were expressed in forms of particle surface
area, the responses of ultrafine and fine TiO2 parti-
cles fell on the same dose–response curve. This sug-
gests that surface area is an important property for
NPs when considering their toxic potential. Also,
there is a study showing that TiO2 in anatase form
was more potent in ROS generation than in rutile
form, revealing the important role of crystal struc-
ture [23]. Under low levels of ultraviolet light, TiO2
nanoparticles could generate ROS and induce cy-
totoxicity because of their photoactivation property
[71]. Another example is ZnO nanoparticles, which
have received significant attention due to their wide
use in sunscreens, electronics, optics and photonics.
However, pulmonary exposure of ZnO nanoparti-
cles could lead to transient increases in acute lung in-
flammation, similarly to a disease called metal fume
fever. It has been shown that the toxicity of ZnO is
dependent on the particle dissolution property and
shedding of toxic Zn ions, which induce oxidative
stress and pro-inflammatory effects in vitro and in
vivo [58,68,71].
In addition to oxidative stress paradigm, recently
studies have found Nod-like receptor protein 3
(NLRP3) inflammasome activation plays a major
role in PM- and NP-induced chronic effects such as
lung fibrosis [49–51,55,56,61,72–75]. Nanomateri-
als including rare earth oxides (REOs), high-aspect-
ratio materials including carbon nanotube (single-
walled andmulti-walled), TiO2 nanobelts andCeO2
nanorods, 2D materials including graphene and
grapheneoxide could induceNLRP3 inflammasome
activation and a series of events leading to epithe-
lial mesenchymal transition and lung fibrosis. Car-
bon nanotubes (CNTs) are a type of long-aspect-
ratio nanomaterial which is drawing wide interest
because of their potential applications in electron-
ics, optics, drug delivery and cancer therapy. How-
ever, animal studies have shown that they could
promote the production of pro-fibrogenic cytokines
and growth factors (IL-1β , TGF-β and PDGF-AA,
etc.) that may lead to lung fibrosis [72–75]. The
mechanism involves cellular uptake of CNTs, over-
produced ROS by NADPH oxidase activation, lyso-
somal damage induced by the surface reactivity of
CNTs and the release of lysosomal protein, cathep-
sin B, which activates NLRP3 inflammasome and
produces IL-1β . IL-1β plays a major role in in-
flammation and fibrosis by activating epithelial mes-
enchymal transition in the lung (Fig. 7) [56,72–
75]. Wang et al. showed that the dispersal state, hy-
drophobicity and purity of multi-walled carbon nan-
otubes (MWCNTs) could affect the pro-fibrogenic
cellular responses that also correlate with the extent
of pulmonary fibrosis [72–75]. Furthermore, other
long-aspect-ratio ENMs also showed similar effects.
Ji et al. demonstrated the toxicological effects of
long-aspect-ratio nanomaterials using a library of in-
house-made CeO2 nanoparticles [76]. In vitro tox-
icity study demonstrated that, at lengths ≥200 nm
and aspect ratios≥22, CeO2 nanorods induced pro-
gressive pro-inflammatory effects and cytotoxicity
[76]. The relatively low ‘critical’ length and aspect
ratio were associated with small nanorod/nanowire
diameters (6–10 nm), which facilitates the forma-
tion of stacking bundles that could pierce through
cell membrane, causing the release of cathepsin B
and further the activation ofNLRP3 inflammasome.
The same CeO2 nanorods could also induce signifi-
cantly higher lung fibrosis than spherical particles in
vivo [77].Our recent studies show that rare earth ox-
ide nanoparticles (REOs), which are widely used in
electronics and upconversion nanoparticles for bio-
imaging, are unstable in the acidic physiological en-
vironment, including the lysosomal compartment of
the cells [49–51]. These REOs can dissolve and the
dissolved ions could bind to phosphates strongly;
as a result, the particles transform from spheres
to ‘sea-urchin’-shaped or mesh-like structures with
composition changes to the RePO4. The sources
of phosphates are not limited to free phosphate
ions in the lysosomal compartment; they also in-
cludephosphate groupson intracellular proteins and
membranes. On the one hand, biotransformation of
REOs could lead to dephosphorylation of phospho-
lipids on the lysosomal membrane, which destabi-
lizes the membrane, leading to lysosomal damage.
Released cathepsin B from lysosomes to the cytosol
REVIEW Xia et al. 427
will activate NLRP3 inflammasomes to produce IL-
1β , which initiate a cascade of events that culminate
inpulmonaryfibrosis [24,26,27].On theother hand,
stripping of phosphate groups from lysosomal pro-
teins will lead to loss of enzymatic activities of the
proteins, resulting in lysosome dysfunction, which
leads to lysosome and autophagosome fusion inhi-
bition and compromised autophagosome degrada-
tion in the autophagy flux. This leads to accumu-
lation of activated NLRP3 inflammasomes because
autophagy is the major homeostatic mechanism to
remove activated inflammasomes [51]. The above
examples show that the physicochemical properties
of NPs determine their toxic potential to human
health, and more research is needed to understand
these interactions between numerous other types of
NPs and biological systems occurring at the nano–
bio interface [18,48,53,66,78].
PREDICTIVE TOXICOLOGICAL APPROACH
TO STUDY AMBIENT ULTRAFINE
PARTICLES AND NANOPARTICLES
Studies have shown that exposure to UFPs and NPs
has the potential to cause adverse health effects in
humans [18,21,22,24,48,53]. In order to assess the
toxic effects of these nano-sized particles, we ad-
vocate a predictive toxicological approach with the
goal of linking particle physicochemical properties
to their toxic effects [18,48,53]. To establish this
predictive toxicological paradigm, there are five ma-
jor requirements. The first is to comprehensively
characterize their physicochemical properties that
may lead to biological injury. It also requires the es-
tablishment of nanomaterial libraries with property
variations, which allows building the link between
material property and the biological/toxicological
activities. The second requirement is to develop in
vitro cellular screening assays that reveal particle-
induced injury mechanisms and pathways such as
oxidative stress and NLRP3 inflammasome activa-
tion.Third,where possible, it is important to develop
high-throughput screening platforms to assess the
large number of material physicochemical proper-
ties, dosage and time points that are likely to lead to
biological injury. Fourth, the in vitro data could be
used for in silicomodeling to establishhazard ranking
and structural-activity relationships that can be used
to predict ENM toxicity. Finally, the in vitro haz-
ard ranking and structural-activity relationships will
thenneed tobevalidatedby limited in vivo animal ex-
periments to establish the ‘predictiveness’ of this ap-
proach. We have successfully demonstrated the use-
fulness of the predictive toxicological approach for
the hazard assessment of over 200 different nano-
materials and development of major structure ac-
tivity relationships for groups of nanomaterials. We
are confident that this approach would facilitate re-
search on the toxicological effects induced by PMs,
UFPs and NPs [53].
CONCLUSIONS
Convincing evidence has established the associa-
tion between PMandmany pulmonary diseases that
contribute to early mortality and reduced life ex-
pectancy. However, for ambient UFPs and NPs, al-
though much progress has been made in under-
standing their toxicological effects and mechanisms
of toxicity, there are still many knowledge gaps on
their impact on human health. In this review, we
have summarized recent major findings on cellu-
lar, animal and human research with a focus on the
respiratory effects and mechanisms of toxicity in-
duced by PM, UFPs and NPs. Available evidence
strongly suggests that UFPs and NPs may be more
potent in causing adverse health effects in humans
because of their high deposition rate in the alveolar
region, impaired clearance by alveolar macrophages
and higher surface reactivity, pro-oxidative and pro-
inflammatory effects than their larger counterparts.
Thus, it is imperative to focus future research on the
health effects of nano-scale pollutants so that pre-
ventive strategies and regulatory guidelines can be
developed to reduce exposure and improve human
health.
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